Key result
Targeting VEGFR2 control circuits offers a promising ligand-independent therapeutic strategy for arteriogenesis.
Answers are grounded in this paper and cite their sources.
Formation of arterial vasculature, here termed arteriogenesis, is a central process in embryonic vascular development as well as in adult tissues. Although the process of capillary formation, angiogenesis, is relatively well understood, much remains to be learned about arteriogenesis. Recent discoveries point to the key role played by vascular endothelial growth factor receptor 2 in control of this process and to newly identified control circuits that dramatically influence its activity. The latter can present particularly attractive targets for a new class of therapeutic agents capable of activation of this signaling cascade in a ligand-independent manner, thereby promoting arteriogenesis in diseased tissues.
No takes yet. Share an insight, caveat, or question.
Simons et al. (2015) conducted a review in Arteriogenesis in embryonic vascular development and adult tissues. Targeting vascular endothelial growth factor receptor 2 was evaluated. Vascular endothelial growth factor receptor 2 and newly identified control circuits play a key role in arteriogenesis and present attractive targets for new ligand-independent therapeutic agents.
Synapse has enriched 10 related papers. Consider them for comparative context: